Monoclonal antibody detection of a circulating tumor-associated antigen. 1. Presence of antigen in sera of patients with colorectal, gastric, and pancreatic carcinoma
Herlyn M, Sears HF, Steplewski Z, Koprowski H. Monoclonal antibody detection of a circulating tumor-associated antigen. 1. Presence of antigen in sera of patients with colorectal, gastric, and pancreatic carcinoma. J. Clin. Immunol. 1982 2 : 135 40.
Antigens of human pancreatic adenocarcinoma cells defined by murine monoclonal antibodies
Metzgar RS, Gaillard MT, Levine SJ, Tuck FL, Bossen EH, Borowitz MJ. Antigens of human pancreatic adenocarcinoma cells defined by murine monoclonal antibodies. Cancer Res. 1982 42 : 601 8.
Genetic evidence for the Lewis enzyme, which synthesizes type-1 Lewis antigens in colon tissue, and intracellular localization of the enzyme
Narimatsu H, Iwasaki H, Nishihara S et al. Genetic evidence for the Lewis enzyme, which synthesizes type-1 Lewis antigens in colon tissue, and intracellular localization of the enzyme. Cancer Res. 1996 56 : 330 8.
Detection of an oncofetal antigen (DU-PAN-2) in sera of patients with non-malignant hepatobiliary diseases and hepatomas
Haviland AE, Borowitz MJ, Killenberg PG, Lan MS, Metzgar RS. Detection of an oncofetal antigen (DU-PAN-2) in sera of patients with non-malignant hepatobiliary diseases and hepatomas. Int. J. Cancer 1988 41 : 789 93.
Reference values and biological variation for tumor marker CA19-9 in serum for different Lewis and secretor genotypes and evaluation of secretor and Lewis genotyping in Caucasian population
Vestergaard EM, Hein HO, Meyer H et al. Reference values and biological variation for tumor marker CA19-9 in serum for different Lewis and secretor genotypes and evaluation of secretor and Lewis genotyping in Caucasian population. Clin. Chem. 1999 45 : 54 61.
Lewis and secretor gene dosage affect CA19-9 and DU-PAN-2 serum levels in normal individuals and colorectal cancer patients
Narimatsu H, Iwasaki H, Nakayama F et al. Lewis and secretor gene dosage affect CA19-9 and DU-PAN-2 serum levels in normal individuals and colorectal cancer patients. Cancer Res. 1998 58 : 512 18.
Extragonadal germ cell tumor with high serum levels of DU-PAN-2
Maeda Y, Fujiwara N, Yoshino T, Kiura K, Ueoka H, Harada M. Extragonadal germ cell tumor with high serum levels of DU-PAN-2. J. Urol. 2002 167 : 246 7.
Multiplex PCR with confronting two-pair primers for Se genotyping
Brinkmann B., Carracedo A. (eds)., Elsevier BV, Amsterdam
Itoh Y, Takahashi K, Satoh K, Nagao K, Fujime M. Multiplex PCR with confronting two-pair primers for Se genotyping. In : Brinkmann B, Carracedo A (eds). Progress in Forensic Genetics, Vol. 10. Elsevier BV, Amsterdam, 2004 602 4.
Immunohistochemical heterogeneity of type 1 blood group antigen expression in testicular germ cell tumors
Kamoshida S, Satoh Y, Yasuda Y, Kajiwara H, Tsukinoki K, Osamura RY. Immunohistochemical heterogeneity of type 1 blood group antigen expression in testicular germ cell tumors. Oncol. Rep. 2002 9 : 845 51.